| Synonyms | NVP-BGT226 |
|---|
| CAS No. | 915020-55-2 |
|---|
| Purity | >98% |
|---|
| Formula | C28H25F3N6O2 |
|---|
| Mol Weight | 534.5323 |
|---|
| Appearance | solid powder |
|---|
| Solubility | Soluble in DMSO, not in water |
|---|
| Shelf Life | >2 years if stored properly |
|---|
| Storage | Powder -20℃ 2 years; In solvent -20℃ 1 month; |
|---|
| Shipping | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
|---|
| |
|---|
| | |
|---|
| Reference: | [1]. Markman B, et al. Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors. Ann Oncol. 2012 Sep;23(9):2399-408.
[2]. Chang KY, et al. Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo. Clin Cancer Res. 2011 Nov 15;17(22):7116-26. |
|---|
| CoA | CoA of BGT226 |
|---|
Inhibitor Specialist 
